After finishing his Ph.D. in biotechnology from the University of Oslo, Morten Isaksen set up several biotech companies in Norway and the UK. He also has experience as a consultant for several biotech companies and academic TTOs. He has more than a decade of experience in the microbiome field and was instrumental in setting up Genetic Analysis (GA) and their core technology. After leaving GA, he continued to develop ideas for improved microbiome profiling technologies. This resulted in Morten founding Bio-Me in 2016. His passion to transform microbiome profiling for better clinical applications has attracted a team of highly skilled and motivated team at Bio-Me.
PMP - A Rapid, Detailed Microbiome Profiling Tool
In order to microbiome analysis to be fully implemented into Precision Medicine regimes, a rapid, detailed and high throughput technology needs to be available. This is what Bio-Me has developed in Precision Microbiome Profiling (PMP™).
Understanding mechanism of action and translating microbiome science into commercially viable therapeutics remains the biggest challenge in this emerging field. With that said, pharma and biotech across many different therapeutic indications and modalities are united in this global effort to bring novel microbiome-based therapies and diagnostics into the clinical domain. This session will include some of the most impactful and promising areas of the microbiome field: